Novel Coronavirus (SARS-CoV-2/COVID-19)
The spread of COVID-19 revealed systemic cracks in the social needs and public health infrastructure of communities — inequities that have existed for decades. A Kaiser Permanente survey of 2,900 of its members earlier this year illustrates the disproportionate impact the pandemic is having on the…
The Food and Drug Administration issued final guidance for health care providers and researchers using investigational COVID-19 convalescent plasma, defined as convalescent plasma that does not meet all conditions of the agency’s emergency use authorization or which is used under an investigational…
The Department of Health and Human Services has released a PPE Preservation Planning Toolkit to help organizations implement strategies to preserve personal protective equipment during the COVID-19 pandemic.
The AHA, American Medical Association and American Nurses Association urged the Trump administration to share all critical information related to COVID-19 with the Biden transition team.
An AHA Member Call on Allocation and Distribution of Operation Warp Speed (OWS) Therapeutics with Nancy Foster and John Redd, MD, CMO, ASPR, including remdesivir and monoclonal antibody (MAB) therapeutics like bamlanivimab through the Emergency Use Authorization (EUA).
Confronting the challenges of the pandemic is imperative to saving American lives. Real-time data and information on the supply of therapeutics, testing supplies, personal protective equipment, ventilators, hospital bed capacity and workforce availability to plan for further deployment of the…
The recently launched AHA Living Learning Network (LLN) provides essential resources through a peer-to-peer community of health care professionals dedicated to helping hospitals and health systems recover, rebuild and reimagine health care while responding to the pandemic.
Moderna Inc. announced that its mRNA-1273 vaccine candidate against COVID-19 is 94.5% effective, according to early data.
The AHA will host a call today, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies.
As of Nov. 6, about 60% of the nation’s retail pharmacies have agreed to participate in a federal program to administer COVID-19 vaccines at no cost to patients once authorized or licensed by the Food and Drug Administration, the departments of Health and Human Services and Defense announced.